Skip to content

Investment Purchases at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$500M+13.6%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$15.01M-90.4%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$486.78M+316%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$819.5M+200%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0-100%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$131M

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.99B-14.9%
Enterprise value$1.57B-24.9%
P/E13.7×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s investment purchases?
Harmony Biosciences Holdings, Inc. (HRMY) reported investment purchases of $179M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s investment purchases changed year-over-year?
Harmony Biosciences Holdings, Inc.'s investment purchases increased by 835.6% year-over-year, from $19.13M to $179M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s investment purchases?
Over 2 years (2023 to 2025), Harmony Biosciences Holdings, Inc.'s investment purchases has grown at a -17.8% compound annual growth rate (CAGR), from $127.47M to $86.15M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.